13 Jun 2022

Connected Devices, Digital Health and Digital Therapeutics: Where are We Heading and Why?

In this webinar, originally broadcast as part of the Pharmapack Europe show, speaker Marcus Bates, Vice President, Digital Healthcare, Aptar Pharma covers an introduction to Connected Devices and the different therapeutic areas that they touch. He also reviews the interaction and interoperability between the connected device and the software platform. He discusses the need for clear definition of the intended use and how this will drive the claims which ultimately leads to the regulatory classification. He also reviews the regulatory classification, regulatory hurdles and the importance of building a road map enabling Real World Data generation. Finally, we will discuss the value and ROI for Connected devices, the most advanced countries for regulatory and reimbursement pathways.

Content provided by our supplier

Aptar Pharma

  • FR
  • 2015
    On CPHI since
  • 5000+
Company types
Packaging supplier/manufacturer

Other Content from Aptar Pharma (39)